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Figure S1. BMP signaling components are expressed in partially overlapping patterns in the regenerate.
(A-E) In situ hybridization of longitudinal ﬁn sections at 3 dpa. (A) bmp7a, a BMP ligand, is expressed in the distal blastema and 
wound epidermis. (B) alk1 is upregulated in the osteoblasts and the distal blastema.  (C-E) alk2, alk3 and alk6 display nearly 
ubiquitous expression with higher levels in osteoblasts and wound epidermis. Dashed lines indicate the plane of amputation.
db, distal blastema;  we, wound epidermis;  ob, osteoblasts. Scale bar in (A), 100 μm. n>3 for each probe. 
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Figure S2. Transgenic manipulation of Bmp signaling results in teratogenic eﬀects. (A) Live imaging of regenerating ﬁns of 
wild type, tg(hsp70:bmp2b) and tg(hsp70:nog3). The same ﬁns are photographed at diﬀerent time points. The ﬁsh were 
exposed to daily heat shock for 10 days after amputation, then transfered to normal conditions for 11 days. Heat shocked wild 
type ﬁsh formed the blastema and normal regenerate. Overexpression of bmp2b completely blocked regeneration in 60% of 
rays and impaired it in 40% of rays. After return to normal conditions rays that had blocked regeneration failed to resume it, 
whereas ﬁns with impaired regeneration resumed regeneration. Overexpression of nog3 (antagonist of Bmp signaling) 
inhibited regeneration (96% of rays) or impaired it (4% of rays) . After return to normal conditions, regeneration was resumed 
in 50% of rays. For all groups number of ﬁns > 4.
(B) Wild type and tg(hsp70:nog3) ﬁsh were left to regenerate for 3 days in normal condition, then exposed to 2 heat shocks 
between 3 and 4 dpa. Induction of nog3 caused a regression of the outgrowth by 50%. Bottom graph shows a quantiﬁcation of 
the length of the regenerate at 3 and 4 dpa in wild type and transgenic ﬁsh (measured by the average of the 2nd, 3rd and 4th 
ray from the edge of the ﬁn on both side). For both groups n = 6 rays in 3 ﬁns, ***p<0.005
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Figure S4. Phenotypic analysis of ﬁn regeneration exposed to diﬀerent DMH1 concentrations. 
(A-E) At 3 dpa, the ﬁns treated with 1, 10 and 20 mM DMH1 formed an outgrowth of slightly smaller size compared to control. 
n=3; ns, P>0.05. At 10 and 20 μM DMH1, blood clots (red) were visible in the outgrowth. 
(F-J) At 10 dpa, the diﬀerence between control and all DMH1-treated ﬁns is statistically signiﬁcant. (G) 1 μM DMH1 delayed 
regeneration by approx. 50%. (H-I) 10 or 20 μM DMH1 resulted in similar severe phenotypes and extensive hemorrhages (red). 
(E and J) Quantiﬁcation of the outgrowth elongation that occurred between 0 and 3 dpa (E), and between 3 and 10 dpa (J) 
n=3; *P<0.05; ***P<0.01. The outgrowth elongation was calculated by measuring the change of the ray length between the 
deﬁned time points. Each ﬁn was represented by the measurements of the second, third and forth ray relative to the edge of
both lobes (Image J software).  The elongation of each individual ray was determined according to the following formula:
0 - 3 dpa, the length of the ray between the amputation plane and the tip of the outgrowth at 3 dpa; 
3 - 10 dpa, the diﬀerence in length of the ray between 3 and 10 dpa. 
The average values of the DMH1-treated animals were calculated as a percentage of control ﬁns that were used as a reference.
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Figure S3. BMP signaling is required for the continuation of the initiated regeneration.
Live imaging of ﬁns at 3 dpa at normal condition (A, B) and after additional 3 days of treatment with either 0.1% DMSO (C), 
or 10 μM DMH1 (D). The regenerate that was formed during the treatment (between 3 and 6 dpa) was twice smaller in 
DMH1-treated ﬁsh than in control ﬁsh. (E) Quantiﬁcation of the outgrowth elongation that occurred between 3 and 6 dpa 
during the treatment. n=3, *P<0.05. 
Outgrowth elongation was calculated by measuring the diﬀerence of the ray length between 3 and 6 dpa with Image J software. 
Each ﬁn was represented by the measurements of the second, third and forth ray relative to the edge of both lobes.  
The average values of DMH1-treated animals were calculated as a percentage of the control ﬁns.
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Figure S6. id3, but not id2a, is expressed in the blood vessels of the rays during ﬁn regeneration.
In situ hybridization and anti-GFP immunostaining of ﬁn sections of transgenic ﬁsh with endothelial reporter. n>3
A
E F
id1 mRNA
control 1 dpa control 2 dpa
G IH J
Figure S5. id1 expression is rapidly suppressed by a pulse treatment with DMH1. (A) Experimental design.  
(B) id1 expression was normalized to beta-actin2 value calibrated to 1. (C-D) pSmad1/5/8 is reduced after 1 day of DMH1. 
(E-F) id1 is expressed at 1 and 2 dpa in wound epidermis and blood vessels of control ﬁns (arrows). 
(G-J) In situ hybridization and anti-GFP immunostaining of transgenic ﬁns with endothelial reporter. id1 expression is reduced 
after 1 day of DMH1 treatment in the distal outgrowth and blood vessels (arrow).
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Figure S7. BMP is required for blood vessel maturation and stabilization. 
(A) Inhibition of VEGF receptor using 1 µM PTK787 completely blocks the initiation of angiogenesis, representing a more 
severe phenotype compared to the one after DMH1 treatment shown in Fig. 4.  
(B) Quantiﬁcation of the total outgrowth length (blue outline of the bars) and its non-vascularized part in control, DMH1 
and PTK787-treated ﬁsh; n>12 (4 rays of at least 3 ﬁns), P<0.001. 
(C) A pulse-treatment with DMH1 for 2 days during the advanced regeneration stage disrupts the structure of 
regenerating vasculature of the blastema. Before drug exposure, at 6 dpa, regular blood vessels were present in the 
blastema. After 2 days of DMH1 treatment, at 8 dpa, these blood vessels dilated and formed an unstructured cluster.  
(D) Confocal images of immunostained ﬁn rays at 8 dpa shown in (C). The distal tip (dashed line) is oriented to the right. 
The vasculature of DMH1-treated blastema resembles a clump of endothelium (green). Fragments of GFP-labeled 
endothelial cells and some blood cells (red; C4 antibody against   Laminin - β2, DSHB) accumulate below the ﬁn margin 
beyond the blood vessels. n=4.
(E) Cell proliferation assay af ter 7h exposure to BrdU (red line in experimental design) during a single day of DMH1-
treatment from 2.5 to 3.5 dpa. Confocal images were used for quantiﬁcation. BrdU (red) and ﬂk1:GFP (green) doubly 
positive nuclei were normalized to the total number of GFP-positive nuclei within the ray outgrowth.  
Manual scoring of cells; n=12 (3 rays of 4 ﬁn), P<0.01. 
